What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression | Zendy

Diana F. Florescu | Zendy; Fang Qiu | Zendy; Megan A. McCartan | Zendy; Cezarina Mindru | Zendy; Paul D. Fey | Zendy; André C. Kalil | Zendy

Open Access

What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression

Author(s) -

Diana F. Florescu,

Fang Qiu,

Megan A. McCartan,

Cezarina Mindru,

Paul D. Fey,

André C. Kalil

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir934

Subject(s) - medicine , ventilator associated pneumonia , meta regression , colistin , pneumonia , intensive care medicine , meta analysis , microbiology and biotechnology , antibiotics , biology

Experience with intravenous and aerosolized forms of colistin for the treatment of ventilator-associated pneumonia (VAP) in patients without cystic fibrosis is limited. We aimed to assess the safety and efficacy of colistin for the treatment of VAP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research